J. George et al., HYPERIMMUNIZATION OF APO-E-DEFICIENT MICE WITH HOMOLOGOUS MALONDIALDEHYDE LOW-DENSITY-LIPOPROTEIN SUPPRESSES EARLY ATHEROGENESIS, Atherosclerosis, 138(1), 1998, pp. 147-152
The role of the immune system in modulating atherosclerosis has recent
ly been the subject of intensive research. Several previous authors ha
ve put forward a paradigm of the autoimmune process occurring in the v
icinity of the plaque. Two recent studies have shown that immunization
of rabbits with homologous modified low-density lipoprotein (LDL) led
to suppression of atherosclerosis. In the current study we evaluated
the effects of homologous malondialdehyde (MDA)-LDL immunizations on a
therogenesis in apo-E-deficient mice. Two groups of female chow-diet-f
ed, apo-E-deficient mice (n = 10) were either immunized with homologou
s MDA-LDL or with phosphate buffer saline (PBS) at 2-week intervals. T
he mice were sacrificed 12 weeks following the primary immunization. T
he MDA-LDL-immunized mice were shown to develop high titers of anti-MD
A-LDL antibodies. Atherosclerosis, determined by the lesion size at th
e aortic sinus, was significantly suppressed in the MDA-LDL-immunized
mice as compared with their littermates immunized with PBS (mean area
+/- S.D.; 74000 +/- 17300 mu m(2) versus 158000 +/- 12800 mu m(2); P <
0.01). No differences were found between the groups with respect to t
he cellular composition of the atherosclerotic plaques. The results of
this study show that immunization with MDA-LDL has a protective effec
t in apo-E-deficient mice, and further suggests that this mouse model
is suitable for studies of immunomodulation. (C) 1998 Elsevier Science
Ireland Ltd. All rights reserved.